Blood Pressure Reduction and ACE Inhibition in Secondary Stroke Prevention: Mechanism Uncertain
- 1 May 2003
- journal article
- editorial
- Published by Wolters Kluwer Health in Stroke
- Vol. 34 (5) , 1335-1336
- https://doi.org/10.1161/01.STR.0000069265.51001.D8
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)JAMA, 2002
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololPublished by Elsevier ,2002
- Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attackThe Lancet, 2001
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000